Jubilant Biosys Limited has over 20 years of experience in delivering Integrated Drug Discovery (IDD) and GMP development and manufacturing. Serving the global pharma industry, Jubilant Biosys employs over 2,400 people operating from five sites in India, with a presence in the USA, Europe, and Japan. The company is recognized in the industry for its scientific innovation, problem-solving mindset, and unwavering attention to customers’ needs.

Jubilant Biosys has evolved as a leading CRDMO (Contract Research, Development, and Manufacturing Organization) partner in science, offering a full spectrum of services in drug discovery, development, and manufacturing. With the addition of biologics such as ADCs (Antibody-Drug Conjugates), mAbs (Monoclonal Antibodies) and large molecules like oligonucleotides, and peptides, the company has grown into an integrated entity, delivering end-to-end solutions from early discovery phases—including biology, medicinal chemistry, DMPK (Drug Metabolism and Pharmacokinetics), and toxicology—to chemical development and manufacturing of GMP (Good Manufacturing Practice) intermediates and APIs (Active Pharmaceutical Ingredients) for both clinical and commercial supplies.

Biosys has consolidated advances in drug discovery by utilizing the latest AI/ML technologies and by incorporation of environment-friendly processes. This enables Biosys to partner with leading companies on the most challenging, cost and time-sensitive drug discovery and development programs. With a strong commitment to new technologies, supply chain, Quality, and ESG considerations, Biosys is a leading CRDMO partner for Big Pharma companies and Biotech.